Journal of Diabetes Research / 2013 / Article / Tab 3

Research Article

Skin Autofluorescence Relates to Soluble Receptor for Advanced Glycation End-Products and Albuminuria in Diabetes Mellitus

Table 3

Skin autofluorescence and novel biochemical parameters in subgroups without (A−) and with (A+) (micro)albuminuria according to ACR.

A+A−ControlsANOVA
( )( )( ) value

AF (AU) cx b <0.0001
Albumin/creatinine (g/mol)13.2cz (3.9–44.0)0.7 (0.3–1.6)0.5 (0.2–1.1)<0.0001
HbA1c (mmol/mol, IFCC) cz c <0.0001
sRAGE (ng/L) x <0.05
vWF (%) b 0.007
sICAM ( g/L) cy 0.0003
sVCAM ( g/L) c c <0.0001
P-selectin ( g/L) b b 0.0008
E-selectin ( g/L) a 0.016

Results are means ± SD, or means with 1 SD range. One-way ANOVA was performed, with values in the last column of the table. Statistical significance expressed by LSD post hoc test between DM and control persons: a , b , and c and between A+ and A−: x , y , z .
Abbreviations: AF: autofluorescence; AU: arbitrary unit; HbA1c: glycated hemoglobin; sRAGE: soluble receptor for advanced glycation end-products; vWF: von Willebrand factor; sICAM: intercellular adhesion molecule; sVCAM: vascular cell adhesion molecule.